Ception Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis (NCT00635089) | Ception Therapeutics | 2008-07-01 |
| Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma (NCT00587288) | Ception Therapeutics | 2008-04-01 |
| Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years (NCT00538434) | Ception Therapeutics | 2008-03-01 |
Track Ception Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.